Lipocine Book Value Per Share from 2010 to 2024

LPCN Stock  USD 5.07  0.20  3.80%   
Lipocine Book Value Per Share yearly trend continues to be very stable with very little volatility. Book Value Per Share is likely to drop to 3.67. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Lipocine according to its financial statements. View All Fundamentals
 
Book Value Per Share  
First Reported
2010-12-31
Previous Quarter
3.86541076
Current Value
3.67
Quarterly Volatility
25.85860817
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Lipocine financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lipocine main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 5.8 M or Total Revenue of 104.5 K, as well as many exotic indicators such as Price To Sales Ratio of 140, Dividend Yield of 0.0048 or PTB Ratio of 0.96. Lipocine financial statements analysis is a perfect complement when working with Lipocine Valuation or Volatility modules.
  
This module can also supplement various Lipocine Technical models . Check out the analysis of Lipocine Correlation against competitors.
To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.

Latest Lipocine's Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Lipocine over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Lipocine's Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lipocine's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 3.83 X10 Years Trend
Slightly volatile
   Book Value Per Share   
       Timeline  

Lipocine Book Value Per Share Regression Statistics

Arithmetic Mean17.53
Coefficient Of Variation147.48
Mean Deviation15.28
Median8.91
Standard Deviation25.86
Sample Variance668.67
Range109
R-Value(0.37)
Mean Square Error623.33
R-Squared0.13
Significance0.18
Slope(2.12)
Total Sum of Squares9,361

Lipocine Book Value Per Share History

2024 3.67
2023 3.87
2022 6.85
2021 8.91
2020 4.68
2019 4.13
2018 7.56

Other Fundumenentals of Lipocine

Lipocine Book Value Per Share component correlations

0.96-0.5-0.540.540.21.00.46-0.080.910.660.66-0.540.050.350.530.53-0.3-0.370.39-0.24-0.05
0.96-0.56-0.390.38-0.070.960.390.080.950.650.54-0.390.040.380.540.56-0.18-0.390.34-0.27-0.05
-0.5-0.56-0.18-0.170.21-0.550.20.13-0.510.250.04-0.120.120.00.20.18-0.24-0.250.22-0.2-0.11
-0.54-0.39-0.18-0.76-0.59-0.52-0.88-0.08-0.49-0.58-0.950.82-0.080.1-0.44-0.410.80.66-0.780.640.44
0.540.38-0.17-0.760.630.540.7-0.380.480.250.79-0.48-0.080.090.270.24-0.76-0.430.66-0.31-0.23
0.2-0.070.21-0.590.630.20.31-0.61-0.10.070.5-0.590.06-0.090.01-0.08-0.430.050.190.110.01
1.00.96-0.55-0.520.540.20.43-0.080.90.610.65-0.540.050.290.460.45-0.26-0.320.34-0.21-0.05
0.460.390.2-0.880.70.310.430.20.510.580.82-0.55-0.080.110.660.66-0.91-0.870.97-0.82-0.56
-0.080.080.13-0.08-0.38-0.61-0.080.20.20.250.04-0.060.13-0.370.040.120.0-0.430.19-0.64-0.5
0.910.95-0.51-0.490.48-0.10.90.510.20.660.65-0.410.00.310.50.52-0.31-0.560.47-0.44-0.21
0.660.650.25-0.580.250.070.610.580.250.660.65-0.560.220.430.750.77-0.39-0.650.55-0.46-0.11
0.660.540.04-0.950.790.50.650.820.040.650.65-0.810.090.00.460.44-0.75-0.660.76-0.56-0.25
-0.54-0.39-0.120.82-0.48-0.59-0.54-0.55-0.06-0.41-0.56-0.81-0.170.11-0.26-0.220.470.32-0.420.290.17
0.050.040.12-0.08-0.080.060.05-0.080.130.00.220.09-0.17-0.120.00.020.180.08-0.130.070.14
0.350.380.00.10.09-0.090.290.11-0.370.310.430.00.11-0.120.690.68-0.07-0.240.20.120.22
0.530.540.2-0.440.270.010.460.660.040.50.750.46-0.260.00.690.99-0.49-0.710.7-0.49-0.12
0.530.560.18-0.410.24-0.080.450.660.120.520.770.44-0.220.020.680.99-0.49-0.730.7-0.52-0.14
-0.3-0.18-0.240.8-0.76-0.43-0.26-0.910.0-0.31-0.39-0.750.470.18-0.07-0.49-0.490.74-0.920.670.41
-0.37-0.39-0.250.66-0.430.05-0.32-0.87-0.43-0.56-0.65-0.660.320.08-0.24-0.71-0.730.74-0.90.920.57
0.390.340.22-0.780.660.190.340.970.190.470.550.76-0.42-0.130.20.70.7-0.92-0.9-0.81-0.46
-0.24-0.27-0.20.64-0.310.11-0.21-0.82-0.64-0.44-0.46-0.560.290.070.12-0.49-0.520.670.92-0.810.73
-0.05-0.05-0.110.44-0.230.01-0.05-0.56-0.5-0.21-0.11-0.250.170.140.22-0.12-0.140.410.57-0.460.73
Click cells to compare fundamentals

About Lipocine Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Lipocine income statement, its balance sheet, and the statement of cash flows. Lipocine investors use historical funamental indicators, such as Lipocine's Book Value Per Share, to determine how well the company is positioned to perform in the future. Although Lipocine investors may use each financial statement separately, they are all related. The changes in Lipocine's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Lipocine's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Lipocine Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Lipocine. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Book Value Per Share 3.87  3.67 
Tangible Book Value Per Share 3.87  3.67 
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Lipocine in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Lipocine's short interest history, or implied volatility extrapolated from Lipocine options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Lipocine offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lipocine's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lipocine Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lipocine Stock:
Check out the analysis of Lipocine Correlation against competitors.
To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.
Note that the Lipocine information on this page should be used as a complementary analysis to other Lipocine's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for Lipocine Stock analysis

When running Lipocine's price analysis, check to measure Lipocine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipocine is operating at the current time. Most of Lipocine's value examination focuses on studying past and present price action to predict the probability of Lipocine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipocine's price. Additionally, you may evaluate how the addition of Lipocine to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
CEOs Directory
Screen CEOs from public companies around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Is Lipocine's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.14)
Revenue Per Share
(0.54)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.37)
Return On Equity
(0.58)
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.